RNAi screens in mice identify physiological regulators of oncogenic growth

S Beronja, P Janki, E Heller, WH Lien, BE Keyes… - Nature, 2013 - nature.com
S Beronja, P Janki, E Heller, WH Lien, BE Keyes, N Oshimori, E Fuchs
Nature, 2013nature.com
Tissue growth is the multifaceted outcome of a cell's intrinsic capabilities and its interactions
with the surrounding environment. Decoding these complexities is essential for
understanding human development and tumorigenesis. Here we tackle this problem by
carrying out the first genome-wide RNA-interference-mediated screens in mice. Focusing on
skin development and oncogenic (HrasG12V-induced) hyperplasia, our screens uncover
previously unknown as well as anticipated regulators of embryonic epidermal growth …
Abstract
Tissue growth is the multifaceted outcome of a cell’s intrinsic capabilities and its interactions with the surrounding environment. Decoding these complexities is essential for understanding human development and tumorigenesis. Here we tackle this problem by carrying out the first genome-wide RNA-interference-mediated screens in mice. Focusing on skin development and oncogenic (HrasG12V-induced) hyperplasia, our screens uncover previously unknown as well as anticipated regulators of embryonic epidermal growth. Among the top oncogenic screen hits are Mllt6 and the Wnt effector β-catenin, which maintain HrasG12V-dependent hyperproliferation. We also expose β-catenin as an unanticipated antagonist of normal epidermal growth, functioning through Wnt-independent intercellular adhesion. Finally, we validate functional significance in mouse and human cancers, thereby establishing the feasibility of in vivo mammalian genome-wide investigations to dissect tissue development and tumorigenesis. By documenting some oncogenic growth regulators, we pave the way for future investigations of other hits and raise promise for unearthing new targets for cancer therapies.
nature.com